Eldian Biomed

Injectable microcushions for joint diseases Eldian Biomed develops CloudLi™ — a tunable lipid-linker platform where linker chemistry defines the therapeutic properties of each asset. Our main focus is CloudLi-1, a lead intra-articular therapy that uses an anti-inflammatory linker to bind lipid nanoparticles into durable micro-cushions that coat damaged cartilage, reduce friction, and suppress inflammation — tackling both drivers of osteoarthritis progression. The CloudLi™ platform also provides a foundation for adjacent musculoskeletal diseases and localized drug-delivery applications.